Down's syndrome risk estimates demonstrate considerable heterogeneity despite homogeneity of input

Annals of Clinical Biochemistry

Volumn 41, Issue 6, 2004, Pages 464-468

  Reynolds, Tim ^a,b   Ellis, Andy ^c   Jones, Rick ^d  

^a QUEEN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

^c UKNEQAS Down's Syndrome Screening   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN;

ADULT; ARTICLE; CALCULATION; CELL HETEROGENEITY; COMPUTER PROGRAM; DOWN SYNDROME; HEALTH SURVEY; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; METHODOLOGY; NORMAL DISTRIBUTION; POPULATION RISK; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; SCREENING; STANDARDIZATION;

ADULT; ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; ESTRIOL; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MASS SCREENING; MATERNAL AGE; MIDDLE AGED; PREGNANCY; PREGNANCY, HIGH-RISK; PRENATAL DIAGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT;

EID: 9644254227     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563042466901     Document Type: Article

References (12)

1. Reynolds T, Penney M. The mathematical basis of multivariate risk analysis: with special reference to screening for Downs syndrome associated pregnancy. Ann Clin Biochem 1990; 27: 452-8
2. Cuckle H, Wald N, Thompson S. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein. Br J Obstet Gynaecol 1987; 94: 387-402
3. Wald N, Cuckle H, Densem G, Nanchahal K, Royston P, Chard T, et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988; 297: 883-7
4. Spencer K, Coombes EJ, Mallards AS, Milford-Ward A. Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers. Ann Clin Biochem 1992; 29: 506-18
5. Wald NJ, Cuckle HS, Densem JW, Kennard A, Smith D. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. Br J Obstet Gynecol 1992; 99: 144-9
6. Cuckle H. Improved parameters for risk estimation in Down's syndrome screening. Prenatal Diagn 1995; 15: 1057-65
7. National Screening Committee: standards for Down's syndrome screening, www.nelh.nhs.uk/screening/dssp/downbestpractice.pdf (Accessed 9 January 2004)
8. Reynolds TM. Fixing detection rates to evaluate false positive rates: a statistical illusion? Chemical Pathology 2004; 1: 12-3
9. Forest J-C, Massé J, Rousseau F, Moutquin J-M, Brideau NA, Bélanger M. Screening for Down syndrome during the first and second trimesters: Impact of risk estimation parameters. Clin Biochem 1995; 28: 443-9
10. Muller F, Aegerter P, Ngo S, Fort A, Beauchet A, Giraudet P, et al. Software for prenatal Down syndrome risk calculation: A comparative study of six software packages. Clin Chem 1999; 45: 1278-80
11. Guibordenche J, Luton D, Takka M, Noel M, Porquet D. Influence of the software algorithm on risk calculation in Down's syndrome screening. Clin Biochem 2000; 33: 679-81
12. Reynolds T. Downs syndrome screening: A controversial test with more controversy to come! J Clin Path 2000; 53: 893-8